Effects of TDCS for Enhancing Cognitive Function in Individuals with Persistent Post-Concussion Syndrome
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Apr 18, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called transcranial direct current stimulation (tDCS) for people who have persistent post-concussion syndrome (PCS) after experiencing a mild traumatic brain injury (TBI). PCS can cause various ongoing symptoms, including difficulties with thinking, physical issues, and emotional challenges. The goal of this study is to see if tDCS, a non-invasive method that gently stimulates the brain, can improve brain function and cognitive abilities, such as processing speed and problem-solving skills, in individuals struggling with PCS.
To participate in this study, you need to be at least 18 years old, have had a mild TBI with a brief loss of consciousness within the last 1 to 6 years, and be able to communicate in Chinese. Unfortunately, if you have certain other neurological or psychiatric conditions, are pregnant, or have any implanted medical devices, you may not be eligible. The trial is not yet recruiting participants, but it aims to explore new ways to help those with PCS manage their symptoms and improve their quality of life. If you decide to join, you can expect to undergo tDCS treatments and possibly some brain imaging tests to help researchers understand how this treatment works.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • being 18 years old or older;
- • having a history of a mild TBI (less than 30 minutes loss of consciousness) 1-6 years prior to the study;
- • able to communicate in Chinese.
- Exclusion Criteria:
- • being without a confirmed diagnosis from the medical practitioner;
- • having a history of other neurological and psychiatric disorders, skull defect, recent medical instability (within 3 weeks);
- • being pregnant;
- • being medication for a psychiatric condition (e.g., major depression, anxiety, schizophrenia);
- • with any implanted devices or suffering from real claustrophobia or feel uncomfortable in small, enclosed spaces, like MRI tunnel
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hung Hom, Kowloon, Hong Kong
Patients applied
Trial Officials
Yvonne Han, PhD
Principal Investigator
The Hong Kong Polytechnic University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported